Mukka Proteins Limited — PPTs, 22-05-2026: Investor Presentation

Mukka Proteins reported strong FY26 performance, with revenue surging to ₹1,449.5 Cr from ₹1,006.4 Cr in FY25. For Q4 FY26, revenue stood at ₹380.6 Cr, with a notable improvement in profitability as EBITDA margin expanded to 12.9% and PAT margin to 5.6%. The company aims for over 2x revenue growth, targeting ₹3,000+ Cr by FY30.

Strategic focus areas include disciplined expansion and diversifying into four synergistic verticals: Fish Protein, Alternate Proteins (Insect Biotech), Waste Management, and Frozen Seafood. Recent developments include securing a major animal waste management contract in Bengaluru and expanding operations into Sri Lanka. Mukka Proteins also received acceptance into the MarinTrust Improver Programme, enhancing its sustainable sourcing efforts, and a new Oman facility is under development. The company is leveraging its integrated model and ESG focus, including significant carbon credit approvals, to capitalize on rising global protein demand and waste-to-value opportunities.